Clinical validation PediGuard has extensive clinical backing with 24 peer‑reviewed publications and real‑time, radiation‑free guidance for pedicle screw placement, signaling strong credibility for surgeons and hospitals evaluating safer spine surgery solutions.

Global adoption Device usage in over 90,000 spinal procedures worldwide indicates a mature reference base and an established track record, suggesting opportunity to upsell to existing users and expand in familiar institutions.

Strategic markets French origin with a niche focus on orthopedic robotics and DSG technology positions SpineGuard well to pursue mid‑size spine centers and regional hospital systems seeking innovative, radiation‑free navigation solutions.

Growth financing With revenue in the low millions and substantial funding, there is financial runway to support sales expansion, clinical partnerships, and training programs to accelerate adoption at new sites.

Key buyers Potential customers include spine surgeon groups, hospital OR directors, and orthopedic vendors seeking safe, accurate pedicle screw placement tools; consider bundled offerings, training, and long‑term service agreements.